Join our daily newsletter At The Bell to receive exclusive market insights
The ASX200 is down just over a third of a per cent.
Most sectors are in the red, with lower oil prices seeing energy shed another 1.75 per cent and being, by far, the worst performer on the market so far today.
Invictus Energy (ASX:IVZ) has been trading up 28 per cent after announcing a gas discovery in the Mukuyu-2 well at Cabora Bassa Project in Zimbabwe.
Invictus owns 80 per cent of the project.
Invictus has been trading at 20.5 cents.
Zip Co (ASX:ZIP) has lifted more than 16.5 per cent thanks to a positive broker note from Citi, which lifted its price target above 50 cents.
Zip Co has been trading at 49 cents.
But uranium play Boss Energy (ASX:BOE) is down more than six per cent after raising A$205 million through a single-tranche placement.
The raise was priced at $3.95 a share.
Proceeds will fund the acquisition of the Alta Mesa uranium mine in Texas from Canadian-listed company Encore Energy. The money will fund the Alta Mesa mine restart and assist in bringing the Honeymoon mine in South Australia into production very soon.
The company’s now looking for another $10 million through a share purchase plan.
BOE has been trading at $3.88.
Augustus Minerals (ASX:AUG) has wrapped up its maiden reverse circulation drilling program at its Ti-Tree project in the Gascoyne region of Western Australia.
78 holes were drilled, for a total of nearly 9100 metres in a bid to verify historical results. The company reported visual copper sulphide was seen in quartz veining through multiple holes at depth.
Assay results are due back within weeks, with planning underway for more drilling early next year.
AUG has been trading at 11.5 cents.
And Little Green Pharma (ASX:LGP) is up more than four per cent on news it’s in a prime position to break into the French market – after a major amendment to the French health security bill paving the way for the integration of medicinal cannabis into the national healthcare system.
First of all, there’ll be a 9-month transitional period during which LGP and select suppliers will exclusively provide medicinal cannabis to existing patients in a pilot program.
Little Green Pharma reports France has a $9.3 billion market potential for the industry.
LGP has been trading at 13 cents.
